« Back
Home /
Anti-LPL Antibody (Center)

Anti-LPL Antibody (Center)

Item no.	BOS-A00316-1-80ul
Manufacturer	Boster
Amount	80 ul
Quantity options	400 ul 80 ul
Category	Metabolism Cholesterol & Lipid Metabolism Flow Cytometry Immunohistochemistry Western Blot Enzymes Fatty Acid Catabolism
Applications	WB, FC, IHC-P
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Alias	Lipoprotein lipase,LPL,LPL,LIPD
Available
Manufacturer - Category	Primary Antibodies
Storage Conditions	Maintain refrigerated at 2-8°C for up to 2 weeks. For long-term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
Molecular Weight	53162 Da
Clonality	Polyclonal
Application Details	WB: 1:1000-1:2000 IHC-P: 1:10-1:50 FC: 1:25
Gene Name	LPL
Background	LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq].
Immunogen	This LPL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 300-327 amino acids from the Central region of human LPL.
Contents	Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide.
Purification	This antibody is purified through a protein A column, followed by peptide affinity purification.
Manufacturer - Research Category	Cancer, Cardiovascular, Metabolism, Signal Transduction
Protein Function	Key enzyme in triglyceride metabolism. Catalyzes the hydrolysis of triglycerides from circulating chylomicrons and very low density lipoproteins (VLDL), and thereby plays an important role in lipid clearance from the blood stream, lipid utilization and storage (PubMed:8675619, PubMed:11342582, PubMed:27578112). Although it has both phospholipase and triglyceride lipase activities it is primarily a triglyceride lipase with low but detectable phospholipase activity (PubMed:7592706, PubMed:12032167). Mediates margination of triglyceride-rich lipoprotein particles in capillaries (PubMed:24726386). Recruited to its site of action on the luminal surface of vascular endothelium by binding to GPIHBP1 and cell surface heparan sulfate proteoglycans (PubMed:11342582, PubMed:27811232).
Subcellular Localization	Cell membrane {ECO:0000250\|UniProtKB:P11151}; Peripheral membrane protein {ECO:0000250\|UniProtKB:P11151}; Extracellular side {ECO:0000250\|UniProtKB:P11151}. Secreted. Secreted, extracellular space, extracellular matrix. Note=Newly synthesized LPL binds to cell surface heparan proteoglycans and is then released by heparanase Subsequently, it becomes attached to heparan proteoglycan on endothelial cells (PubMed:27811232). Locates to the plasma membrane of microvilli of hepatocytes with triglyceride-rich lipoproteins (TRL) Some of the bound LPL is then internalized and located inside non- coated endocytic vesicles (By similarity) {ECO:0000250\|UniProtKB:P11151, ECO:0000269\|PubMed:27811232}
Description	Boster Bio Anti-LPL Antibody (Center) (Catalog # A00316-1). Tested in WB, IHC-P, Flow Cytometry application(s). This antibody reacts with Human.
Tissue Specificity	Detected in blood plasma (PubMed:2340307, PubMed:11893776, PubMed:12641539). Detected in milk (at protein level) (PubMed:2340307).
Predicted Reactivity	Bovine, Mouse, Pig, Rat, Sheep

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

BOS-A00316-1-80ul-datasheet.pdf

BOS-A00316-1-80ul-safety-datasheet.pdf